Reply to D. Pouessel et al, J.B. Aragon-Ching, and B.A. Adesunloye

MeSH terms

• Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
• Biomarkers, Tumor / analysis*
• Carcinoma, Transitional Cell / chemistry*
• Carcinoma, Transitional Cell / drug therapy*
• Cystectomy*
• Female
• Granulocyte Colony-Stimulating Factor / therapeutic use*
• Humans
• Male
• Neoadjuvant Therapy / methods*
• Protective Agents / therapeutic use*
• Urinary Bladder Neoplasms / chemistry*
• Urinary Bladder Neoplasms / drug therapy*